MedPath

Marlex Pharmaceuticals, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

91

FDA:91

Drug Approvals

Dexamethasone

Approval Date
Apr 22, 2025
FDA

Oxcarbazepine

Approval Date
Apr 14, 2025
FDA

Ezetimibe

Approval Date
Jan 1, 2024
FDA

Nadolol

Approval Date
Dec 4, 2023
FDA

PYRAZINAMIDE

Approval Date
Dec 4, 2023
FDA

Promethazine Hydrochloride

Approval Date
Nov 22, 2023
FDA

Prazosin Hydrochloride

Approval Date
Nov 17, 2023
FDA

Ropinirole

Approval Date
Nov 15, 2023
FDA

Probenecid

Approval Date
Nov 15, 2023
FDA

Lidocaine Hydrochloride

Approval Date
Nov 15, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.